Regulatory News:
Arcam (STO:ARCM), listed on NASDAQ OMX, has received an order for an EBM system from a client in the UK. The system will be delivered in 2014.
The above information has been made public in accordance with the Securities Market Act and/or the Financial Instruments Trading Act. The information was published on December 2, 2013.
Arcam provides a cost-efficient Additive Manufacturing solution for production of metal components. The technology offers freedom in design combined with excellent material properties and high productivity. Arcam's market is global with customers mainly in the orthopedic and aerospace industries. The company was founded in 1997 and is listed on NASDAQ OMX Stockholm, Sweden. Head office and production facilities are located in Mölndal, Sweden. Support offices are located in the US, UK, Italy and China.
Arcam AB • Krokslätts Fabriker 27A SE-431 37 Mölndal, Sweden 46-31-710 32 00 www.arcam.com
This information was brought to you by Cision http://news.cision.com
Contacts:
Arcam AB
Magnus René, CEO
Tel: 46 31 710 32 00
alt. cell: 46 702 79 89 99
E-mail: magnus.rene@arcam.com